Tuesday, January 25, 2022

TOPIC

DRDO

The Philippines is getting BrahMos: India’s proposal to supply Brahmos anti-ship Missile System gets green signal

Philippines has accepted BrahMos Aerospace Pvt Ltd's proposal worth USD 374.9 million to supply a Shore-Based Anti-Ship Missile System Acquisition Project for its navy

DRDO scientist planted bomb at Rohini court in bid to kill neighbour: Delhi Police

Delhi Police arrested Bharat Bhushan Kataria, a DRDO scientist for planting a bomb in Rohini court to kill his neighbour

India successfully tests fire new-generation ballistic missile Agni-P with nuclear capabilities

Agni-P is a two-staged nuclear-capable ballistic missile using solid propellants, with improved manoeuvring and accuracy.

PM Modi to formally hand over the first made-in-India light combat helicopter to the Indian Air Force

PM Modi will formally hand over the indigenously developed Light Combat Helicopter (LCH) to the Indian Air Force today in Jhansi, Uttar Pradesh

PM CARES Fund: DRDO to set up 850 oxygen plants across the country

Government of India has ordered DRDO to setup 850 oxygen plants across country under PM CARES Fund

‘Messiah’ Sonu Sood promises to arrange 2-DG drug for patient, although it is commercially unavailable

Sonu Sood courted controversy after he promised to arrange the indigenous anti-COVID oral drug 2-deoxy-D-glucose (2-DG).

Anti-viral drug 2-DG is not commercially available yet, do not fall prey to fraudsters: warns Dr. Reddy’s Laboratories

Dr Reddy's said that commercial launch and supply of 2DG to major government and private hospitals is expected to commence in mid-June

‘This is your blessing’: INMAS director whose team developed 2-DG drug thanks his physics teacher Rajnath Singh

Dr AK Mishra, the director of INMAS, stated that Raksha Mantri Rajnath Singh was his physics lecturer back in the 1980s.

First batch of anti-COVID oral drug 2-DG launched: All you need to know about the DRDO-developed medicine

India's indigenous anti-viral oral 2-DG drug is expected to be made available to all hospital by June, 2020

Patanjali was the first Indian company to publish a research paper on the new Covid-19 drug approved by DCGI: Read details

Patanjali had published a research paper on use of the drug 2-deoxy-D-glucose for Covid-19 treatment in March 2020

Latest News

Recently Popular

Connect with us

255,564FansLike
585,296FollowersFollow
25,600SubscribersSubscribe